Cargando…
Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices
IMPORTANCE: Undiagnosed atrial fibrillation (AF) is an important cause of stroke. Screening for AF using wrist-worn wearable devices may prevent strokes, but their cost-effectiveness is unknown. OBJECTIVE: To evaluate the cost-effectiveness of contemporary AF screening strategies, particularly wrist...
Autores principales: | Chen, Wanyi, Khurshid, Shaan, Singer, Daniel E., Atlas, Steven J., Ashburner, Jeffrey M., Ellinor, Patrick T., McManus, David D., Lubitz, Steven A., Chhatwal, Jagpreet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356321/ https://www.ncbi.nlm.nih.gov/pubmed/36003419 http://dx.doi.org/10.1001/jamahealthforum.2022.2419 |
Ejemplares similares
-
Comparative Clinical Effectiveness of Population‐Based Atrial Fibrillation Screening Using Contemporary Modalities: A Decision‐Analytic Model
por: Khurshid, Shaan, et al.
Publicado: (2021) -
Effect of clinic-based single-lead electrocardiogram rhythm assessment on oral anticoagulation prescriptions in patients with previously diagnosed atrial fibrillation
por: Ashburner, Jeffrey M., et al.
Publicado: (2023) -
Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021) -
Characteristics and Attitudes of Wearable Device Users and Non-Users in a Large Healthcare System
por: Venn, Rachael A., et al.
Publicado: (2023) -
Screening for undiagnosed atrial fibrillation using a single-lead electrocardiogram at primary care visits: patient uptake and practitioner perspectives from the VITAL-AF trial
por: Atlas, Steven J., et al.
Publicado: (2023)